|
|
regulation of endocytic recycling
|
GO:2001135 |
3 |
1.000
|
|
|
|
positive regulation of endocytic recycling
|
GO:2001137 |
2 |
0.999
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.993
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.989
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.978
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.971
|
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.960
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.937
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.936
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.934
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.918
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.905
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.898
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.893
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.875
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.874
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.869
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.857
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.836
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.828
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.810
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.798
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.779
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.776
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.768
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.763
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.758
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.754
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.752
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.745
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.744
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.729
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.724
|
|
|
|
vascular endothelial growth factor signaling pathway
|
GO:0038084 |
10 |
0.720
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.715
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.713
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.711
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.704
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.703
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.698
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.696
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.687
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.674
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.672
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.665
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.660
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.656
|
|
|
|
positive regulation of protein localization to plasma membrane
|
GO:1903078 |
7 |
0.655
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.651
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.645
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.640
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.632
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.632
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.624
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.623
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.619
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.618
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.617
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.616
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.614
|
|
|
|
protein targeting to membrane
|
GO:0006612 |
20 |
0.614
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.606
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.604
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.594
|
|
|
|
metanephric glomerular endothelium development
|
GO:0072264 |
1 |
0.593
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.593
|
|
|
|
positive regulation of p38mapk cascade
|
GO:1900745 |
1 |
0.590
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.579
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.578
|
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.572
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.572
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.570
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.564
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.558
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.554
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.552
|
|
|
|
regulation of myeloid dendritic cell activation
|
GO:0030885 |
5 |
0.547
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.547
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.545
|
|
|
|
regulation of necrotic cell death
|
GO:0010939 |
13 |
0.542
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.539
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.534
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.527
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.523
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.517
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.516
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.514
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.512
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.509
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.505
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.505
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.501
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.496
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.496
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.492
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.491
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.491
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.483
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.482
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.479
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.470
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.469
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.468
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.465
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.463
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.454
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.450
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
10 |
0.448
|
|
|
|
protein targeting to plasma membrane
|
GO:0072661 |
7 |
0.446
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.441
|
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.437
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.433
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.433
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.431
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.429
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.428
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.425
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.423
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.421
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.421
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.420
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.419
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.415
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.409
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.405
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.401
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.399
|
|
|
|
regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902253 |
13 |
0.394
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.394
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.393
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.390
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.387
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.381
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.379
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.378
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.378
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.377
|
|
|
|
pronephric nephron development
|
GO:0039019 |
1 |
0.374
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.371
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.367
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.364
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.364
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.361
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.360
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.359
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.359
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.358
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.350
|
|
|
|
mitochondrial dna replication
|
GO:0006264 |
7 |
0.350
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.349
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.349
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.348
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.346
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.345
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.343
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.341
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.334
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.332
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.328
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.326
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.325
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.325
|
|
|
|
positive regulation of establishment of protein localization to plasma membrane
|
GO:0090004 |
7 |
0.323
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.320
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.319
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.318
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.317
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.316
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.315
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.313
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.312
|
|
|
|
protein localization to endosome
|
GO:0036010 |
2 |
0.311
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.309
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.309
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.308
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.304
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.303
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.300
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.300
|
|
|
|
positive regulation of mitotic cell cycle embryonic
|
GO:0045977 |
2 |
0.300
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.299
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.296
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.295
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.293
|
|
|
|
deoxyribonucleotide biosynthetic process
|
GO:0009263 |
6 |
0.293
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.293
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.291
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.288
|
|
|
|
metanephric glomerulus vasculature development
|
GO:0072239 |
7 |
0.287
|
|
|
|
metanephric mesangial cell differentiation
|
GO:0072209 |
1 |
0.287
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.285
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.284
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.282
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.279
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.278
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.275
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.275
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.275
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.273
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.272
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.271
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.270
|
|
|
|
regulation of endothelial cell chemotaxis
|
GO:2001026 |
1 |
0.269
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.266
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.265
|
|
|
|
negative regulation of endoplasmic reticulum calcium ion concentration
|
GO:0032471 |
3 |
0.264
|
|
|
|
hindbrain radial glia guided cell migration
|
GO:0021932 |
12 |
0.263
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.263
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.261
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.261
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.259
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.258
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.253
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.251
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.247
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.246
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.246
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.246
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.245
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.245
|
|
|
|
glomerular epithelium development
|
GO:0072010 |
11 |
0.244
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.243
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.241
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.241
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.240
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.239
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.239
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.237
|
|
|
|
neuropilin signaling pathway
|
GO:0038189 |
2 |
0.236
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.235
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.235
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.234
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.232
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.232
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.232
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.230
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.228
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.227
|
|
|
|
positive regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway
|
GO:1903378 |
3 |
0.225
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.225
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.225
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.225
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.223
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.223
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.222
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.221
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.220
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.219
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.218
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.218
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.216
|
|
|
|
regulation of pigment cell differentiation
|
GO:0050932 |
7 |
0.215
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.214
|
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
11 |
0.214
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.212
|
|
|
|
deoxyribonucleoside triphosphate metabolic process
|
GO:0009200 |
9 |
0.212
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.210
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.210
|
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.209
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.208
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.207
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.207
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.206
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.205
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.205
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.204
|
|
|
|
negative regulation of rho protein signal transduction
|
GO:0035024 |
7 |
0.204
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.203
|
|
|
|
positive regulation of endothelial cell chemotaxis
|
GO:2001028 |
1 |
0.202
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.200
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.200
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.199
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.199
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.196
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.194
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.194
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.193
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.193
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.193
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.193
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.193
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.193
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.191
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.189
|
|
|
|
induction of positive chemotaxis
|
GO:0050930 |
7 |
0.188
|
|
|
|
positive regulation of smooth muscle contraction
|
GO:0045987 |
7 |
0.188
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.187
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.187
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.187
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.187
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.186
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.186
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.185
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.184
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:0097296 |
2 |
0.184
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.183
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.183
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.182
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.179
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.176
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.175
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.175
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.175
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.174
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.172
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.172
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.172
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.171
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.170
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.170
|
|
|
|
regulation of metanephric glomerulus development
|
GO:0072298 |
5 |
0.170
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.170
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.170
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.169
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.168
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.168
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.168
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.167
|
|
|
|
adrenergic receptor signaling pathway
|
GO:0071875 |
13 |
0.166
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.166
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.166
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.166
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.166
|
|
|
|
positive regulation of protein targeting to membrane
|
GO:0090314 |
7 |
0.165
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.164
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.164
|
Mouse |
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.164
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.162
|
|
|
|
negative regulation of myeloid dendritic cell activation
|
GO:0030886 |
3 |
0.162
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.162
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.161
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.161
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.161
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.159
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.159
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.158
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.158
|
|
|
|
rhombomere 5 formation
|
GO:0021666 |
1 |
0.158
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.157
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.157
|
|
|
|
s shaped body morphogenesis
|
GO:0072050 |
6 |
0.156
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.155
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.155
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.155
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.155
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.154
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.153
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.152
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.151
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.150
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.150
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.149
|
|
|
|
regulation of activation of jak2 kinase activity
|
GO:0010534 |
1 |
0.149
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.149
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.148
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.147
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c
|
GO:0008635 |
4 |
0.145
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.145
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.144
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.143
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.143
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.143
|
|
|
|
positive regulation of muscle contraction
|
GO:0045933 |
10 |
0.142
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.141
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.141
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.141
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.138
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.138
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.137
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.136
|
|
|
|
mitochondrial outer membrane permeabilization
|
GO:0097345 |
10 |
0.136
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.135
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.135
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.135
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.134
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.134
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.133
|
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
4 |
0.133
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.133
|
|
|
|
negative regulation of neurotransmitter transport
|
GO:0051589 |
7 |
0.133
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.132
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.132
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.131
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.131
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.131
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.131
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.131
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
3 |
0.130
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.129
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.129
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.128
|
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
1 |
0.127
|
|
|
|
regulation of branching involved in salivary gland morphogenesis by epithelial mesenchymal signaling
|
GO:0060683 |
1 |
0.127
|
|
|
|
post embryonic camera type eye development
|
GO:0031077 |
8 |
0.126
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.124
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.124
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.124
|
|
|
|
mitochondrial genome maintenance
|
GO:0000002 |
15 |
0.124
|
|
|
|
regulation of glomerular filtration
|
GO:0003093 |
3 |
0.123
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.123
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.123
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.123
|
|
|
|
positive regulation of b cell apoptotic process
|
GO:0002904 |
4 |
0.123
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.118
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.118
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.117
|
|
|
|
angiotensin activated signaling pathway
|
GO:0038166 |
4 |
0.117
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.117
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.117
|
|
|
|
negative regulation of metanephric glomerulus development
|
GO:0072299 |
1 |
0.117
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.117
|
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
17 |
0.116
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.116
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.115
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.115
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.114
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.114
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.114
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.114
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.113
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.113
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.113
|
|
|
|
gamma delta t cell differentiation
|
GO:0042492 |
11 |
0.112
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.112
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.112
|
|
|
|
apoptotic process involved in embryonic digit morphogenesis
|
GO:1902263 |
3 |
0.111
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.110
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.110
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.110
|
|
|
|
response to fructose
|
GO:0009750 |
2 |
0.110
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.110
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.109
|
|
|
|
regulation of lymphangiogenesis
|
GO:1901490 |
3 |
0.108
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.108
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.107
|
Mouse |
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.107
|
|
|
|
metanephric part of ureteric bud development
|
GO:0035502 |
2 |
0.106
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.106
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.105
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.104
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.104
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.104
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.104
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.103
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.103
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.102
|
Mouse |
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.101
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.101
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.101
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.101
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.100
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.100
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.099
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.099
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.098
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.098
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.098
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.097
|
|
|
|
positive regulation of phosphatase activity
|
GO:0010922 |
4 |
0.096
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.096
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.096
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.095
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.095
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.095
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.095
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.095
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.094
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.094
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.094
|
|
|
|
response to macrophage colony stimulating factor
|
GO:0036005 |
3 |
0.093
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.093
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.093
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.093
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.093
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.093
|
|
|
|
response to ketone
|
GO:1901654 |
15 |
0.093
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.093
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.093
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.092
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.092
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.091
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.091
|
|